Home
About
News & Events

News & Events

Nordic Bioscience Holding A/S Annual Report 2025 Highlights

We want to thank our dedicated colleagues, partners, and clients for their continued support. Together, we are driving earlier disease detection, better patient outcomes, and more effective treatments. For any questions or inquiry, please contact us at bd@nordicbioscience.com.

Read article

GRIPonMASH Reaches Major Milestone: Over 5,000 Participants Enrolled and 25,000+ Samples Collected Across Europe

European study reaches halfway point of ambitious goal of screening 10,000 individuals at risk of MASLD Utrecht, The Netherlands, May 19, 2026: The GRIPonMASH project has reached a significant milestone in its mission to improve early detection and understanding of metabolic dysfunction-associated steatotic liver disease (MASLD). More than 5,000 participants, representing over 50% of the […]

Read article

Latest events May 13, 2026

Collagen Remodeling in Intestinal Fibrosis | Webinar

Collagen Remodeling in Intestinal Fibrosis: Non-invasive monitoring and emerging therapies Overview Join our webinar to learn more about intestinal fibrosis in inflammatory bowel disease, with a focus on extracellular matrix remodeling, collagen biomarker assessment, and emerging therapeutic strategies for fibrostenotic complications in Crohn’s disease and ulcerative colitis. Agenda Introduction and welcome | Prof. Dr. Morten Karsdal Navigating […]

Read article

Latest events April 13, 2026

DDW 2026

Nordic Bioscience’s gastroenterology team will be attending Digestive Disease Week (DDW) 2026, held May 2–5, 2026, in Chicago, IL. As one of the largest global events in digestive health, DDW brings together clinicians, researchers, and industry to share advances across gastroenterology, hepatology, and endoscopy. At this year’s meeting, we will be exhibiting at Booth #1832, […]

Read article

Latest events March 24, 2026

ECM Remodeling and Precision Trials in Pulmonary Diseases | Webinar

From Heterogeneity to Biology: ECM Remodeling and Precision Trials in Pulmonary Diseases Join this ECM Pharmacology Symposium to explore whether current approaches truly capture the underlying biology of pulmonary diseases such as COPD and lung cancer. This session focuses on extracellular matrix (ECM) remodeling as a central disease mechanism, its role in disease heterogeneity, and […]

Read article

Spring/Summer Conference Season (Q1-Q2)

Find an overview of the conferences Nordic Bioscience will be attending in Q1-Q2. This year’s conference season has begun, and we look forward to the upcoming months with conferences in Europe, North America and Asia. Our team will share our newest insights from various disease areas in verbal presentations and posters, and we look forward […]

Read article

News

Morten Karsdal, CEO of Nordic Bioscience, Receives the Arthur D. Little Nordic Life Science Award

April 14, 2023

Read article

Pliant Therapeutics Publishes Positive Data From Their INTEGRIS-IPF Phase 2a Trial of Bexotegrast Featuring PRO-C3 Biomarker

January 24, 2023

Read article

Best Of 2022 Publications Digest

January 3, 2023

Read article

Madrigal Pharmaceuticals Takes a Major Step Toward Improving the Lives of NASH Patients with the Help of the PRO-C3 Biomarker

December 20, 2022

Read article

NEJM Evidence Study on PRO-C6 Followed up by Two Editorials

September 30, 2022

Read article

PRESS RELEASE: Research Published in NEJM Evidence Positions Nordic Bioscience’s PRO-C6 as Next-Generation Biomarker Assay for Trial Enrichment in HFpEF

September 14, 2022

Read article

1 … 4 5 6 7 8

Upcoming events

No upcoming events

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Cardiovascular diseases

Dermatology

Gastrointestinal diseases

Hepatic diseases

Kidney diseases

Neuroscience

Obesity

Oncology

Respiratory diseases

Rheumatic diseases

What we offer

Biomarker portfolio

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Our services

Lab solutions

Biomarker Solutions

Biomarker Portfolio

Why Biomarkers?

Kit in a Box

Measure specific protein fragments

Our technology

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

About Nordic Bioscience

Who we are

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Cardiovascular diseases

Dermatology

Gastrointestinal diseases

Hepatic diseases

Kidney diseases

Neuroscience

Obesity

Oncology

Respiratory diseases

Rheumatic diseases

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Biomarker Solutions

Biomarker Portfolio

Why Biomarkers?

Kit in a Box

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

News & Events

Nordic Bioscience Holding A/S Annual Report 2025 Highlights

GRIPonMASH Reaches Major Milestone: Over 5,000 Participants Enrolled and 25,000+ Samples Collected Across Europe

Collagen Remodeling in Intestinal Fibrosis | Webinar

DDW 2026

ECM Remodeling and Precision Trials in Pulmonary Diseases | Webinar

Spring/Summer Conference Season (Q1-Q2)

News

Morten Karsdal, CEO of Nordic Bioscience, Receives the Arthur D. Little Nordic Life Science Award

Pliant Therapeutics Publishes Positive Data From Their INTEGRIS-IPF Phase 2a Trial of Bexotegrast Featuring PRO-C3 Biomarker

Best Of 2022 Publications Digest

Madrigal Pharmaceuticals Takes a Major Step Toward Improving the Lives of NASH Patients with the Help of the PRO-C3 Biomarker

NEJM Evidence Study on PRO-C6 Followed up by Two Editorials

PRESS RELEASE: Research Published in NEJM Evidence Positions Nordic Bioscience’s PRO-C6 as Next-Generation Biomarker Assay for Trial Enrichment in HFpEF

Upcoming events